Zuyderland Medisch Centrum Stichting

At Zuyderland Medisch Centrum Stichting, research in neoplasms and blood cancers focuses on improving treatment outcomes for patients with a wide range of solid tumors and hematologic malignancies. The studies explore new combinations and treatment strategies for cancers such as breast cancer, non-small cell lung cancer, gastric cancer, urothelial cancer, melanoma, and multiple forms of leukemia and lymphoma.

• Testing new cancer therapies and combination approaches to improve survival and disease control
• Evaluating treatment effectiveness in advanced breast cancer, prostate cancer, and lung cancer
• Studying better options for acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, and diffuse large B-cell lymphoma

These trials reflect a strong focus on refining cancer care through more effective and personalized treatment approaches.

Clinical research in nervous system diseases is especially active in multiple sclerosis, with studies covering relapsing, progressive, and primary progressive disease forms. The work aims to better control disease activity, slow disability progression, and assess the long-term safety and effectiveness of treatments used in everyday care.

• Assessing therapies for relapsing multiple sclerosis, progressive multiple sclerosis, and primary progressive multiple sclerosis
• Evaluating long-term safety and real-world effectiveness of established multiple sclerosis treatments
• Exploring personalized treatment approaches to improve disease control and reduce disability

This area highlights the site’s interest in both new and ongoing strategies for people living with chronic neurological disease.

Research in digestive system diseases includes studies for ulcerative colitis and Crohn’s disease, with attention to symptom control, endoscopic response, and longer-term safety of treatment options. The goal is to improve everyday disease management for people with chronic intestinal inflammation.

• Testing new therapies for mild-to-moderate ulcerative colitis and more active forms of Crohn’s disease
• Measuring how well treatments reduce intestinal inflammation and improve clinical remission
• Following longer-term safety and tolerability of therapies used for chronic bowel disease

These studies support more effective and better-tolerated care for patients with long-standing gastrointestinal disease.

The site also conducts research across male urogenital diseases and cardiovascular and kidney-related conditions, including studies in metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, and chronic kidney disease. This work aims to improve survival, delay progression, and better manage major complications.

• Evaluating new treatment strategies for advanced prostate cancer
• Studying therapies intended to improve kidney and heart-related outcomes in high-risk patients
• Exploring ways to better control disease progression and support long-term care

These trials show a broad interest in conditions that often require coordinated, long-term internal medicine care.

Research in hormonal diseases and reproductive and urinary physiological phenomena includes studies on hypothyroidism, polycystic ovary syndrome, and treatment-related fatigue. The focus is on improving symptoms, quality of life, and the day-to-day impact of chronic endocrine disorders.

• Comparing treatment approaches for persistent tiredness in autoimmune hypothyroidism
• Studying fertility-related treatment strategies in polycystic ovary syndrome
• Assessing whether tailored care can better match treatment to individual patient needs

At this hospital-based research site, these studies aim to make chronic hormone-related conditions easier to live with.

Work in musculoskeletal diseases and environment and public health includes research on preventing venous thromboembolism after joint replacement, alongside studies that look at broader care organization and treatment safety. The aim is to improve prevention strategies and support safer recovery for patients.

• Comparing thrombosis prevention approaches after hip and knee arthroplasty
• Studying which patients may benefit from more individualized prevention plans
• Evaluating ways to improve patient safety and care efficiency in routine practice

These trials add a practical, prevention-focused dimension to the research portfolio at Zuyderland Medisch Centrum Stichting.